Lin Long
No. 61 Jiefangxi Road
Changsha, 410005, China
Changsha, 410005, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Discovery of a novel 10-hydroxy-12-methyl-substituted evodiamine derivative with anti-hepatocellular carcinoma activity through multi-pathway modulation involving suppression of PKA/AKT signaling cascades and moderate Topo I inhibition.
Journal: European journal of medicinal chemistry
Published: May 06, 2026
Machine learning prediction of 30-day all-cause mortality risk factors in HCC rupture.
Journal: Frontiers in oncology
Published: January 27, 2026
Generative AI-based low-dose digital subtraction angiography for intra-operative radiation dose reduction: a randomized controlled trial.
Journal: Nature medicine
Published: January 23, 2025
STC2 knockdown inhibits cell proliferation and glycolysis in hepatocellular carcinoma through promoting autophagy by PI3K/Akt/mTOR pathway.
Journal: Archives of biochemistry and biophysics
Published: April 18, 2024
Design, synthesis, and biological evaluation of 1-styrenyl isoquinoline derivatives for anti-hepatocellular carcinoma activity and effect on mitochondria.
Journal: European journal of medicinal chemistry
Published: November 01, 2022
Expert consensus on emergency procedures for portal hypertension bleeding (2022).
Journal: Journal of interventional medicine
Published: August 21, 2022
Verbascoside enhances radiosensitivity of hepatocellular carcinoma cells through regulating miR-101-3p/Wee1 axis.
Journal: Drug development research
Published: July 29, 2021
Endovascular Stent Graft Treatment of Stanford Type B Aortic Dissection with Retrograde Type A Intramural Haematoma: A Multicentre Retrospective Study.
Journal: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
Published: October 14, 2020
CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.
Journal: Technology in cancer research & treatment
Published: March 14, 2019
ZEB1 mediates doxorubicin (Dox) resistance and mesenchymal characteristics of hepatocarcinoma cells.
ZEB1 mediates doxorubicin (Dox) resistance and mesenchymal characteristics of hepatocarcinoma cells.
Journal: Experimental and molecular pathology
Published: August 06, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026